Liver fluke vaccines in ruminants: Strategies, progress and future opportunities

International Journal for Parasitology

Volumn 44, Issue 12, 2014, Pages 915-927

  Toet, Hayley ^a   Piedrafita, David M ^b   Spithill, Terry W ^a  

^a LA TROBE UNIVERSITY   (Australia)

^b UNIVERSITY OF BALLARAT   (Australia)

Author keywords

Acquired immunity; Fasciola gigantica; Fasciola hepatica; Liver fluke; Tegument proteins; Vaccine

Indexed keywords

FLUKE VACCINE; PARAMYOSIN; TRICLABENDAZOLE; UNCLASSIFIED DRUG; VACCINE; ANTIPLATYHELMINTIC AGENT; BENZIMIDAZOLE DERIVATIVE; MEMBRANE ANTIGEN; PARASITE ANTIGEN;

ANTIBODY; ANTIGEN; CHEMICAL CONTROL; DISEASE PREVALENCE; EFFICIENCY MEASUREMENT; FLATWORM; IMMUNE RESPONSE; IMMUNITY; INFECTIOUS DISEASE; LIVESTOCK; PARASITE; PROTEIN; RODENT; RUMINANT; STRATEGIC APPROACH; VACCINATION; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; BOVIDS; CATTLE; CONTROLLED STUDY; DRUG EFFICACY; ECONOMIC ASPECT; FASCIOLA; FASCIOLA HEPATICA; FASCIOLIASIS; HERD; IMMUNE RESPONSE; INFECTION RISK; LIVESTOCK; NONHUMAN; PREVALENCE; REVIEW; SHEEP; TREMATODIASIS; ADAPTIVE IMMUNITY; ANIMAL; BOVINE; DOMESTIC SHEEP; IMMUNOLOGY; PARASITOLOGY; RUMINANT; SHEEP DISEASES; SYNTHESIS; VETERINARY;

FASCIOLA GIGANTICA; FASCIOLA HEPATICA;

ADAPTIVE IMMUNITY; ANIMALS; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, HELMINTH; ANTIGENS, SURFACE; ANTIPLATYHELMINTIC AGENTS; BENZIMIDAZOLES; CATTLE; FASCIOLA HEPATICA; FASCIOLIASIS; RUMINANTS; SHEEP; SHEEP DISEASES; SHEEP, DOMESTIC; VACCINES;

EID: 84908218202     PISSN: 00207519     EISSN: 18790135     Source Type: Journal    
DOI: 10.1016/j.ijpara.2014.07.011     Document Type: Review

References (148)

1. A'Gadir H., Haroun E.M., Gameel A.A. The protective effect of irradiated metacercariae of Fasciola gigantica against homologous challenge in sheep. J. Helminthol. 1987, 61:137-142.
2. Almeida M.S., Torloni H., Lee-Ho P., Vilar M.M., Thaumaturgo N., Simpson A.J., Tendler M. Vaccination against Fasciola hepatica infection using a Schistosoma mansoni defined recombinant antigen, Sm14. Parasite Immunol. 2003, 25:135-137.
3. Anon., 1995. Control of Foodborne Trematode Infections. WHO Technical Series No. 849. World Health Organisation, Geneva.
4. Bassetto C.C., Silva B.F., Newlands G.F., Smith W.D., Amarante A.F. Protection of calves against Haemonchus placei and Haemonchus contortus after immunization with gut membrane proteins from H. contortus. Parasite Immunol. 2011, 33:377-381.
5. Bassetto C.C., Silva M.R., Newlands G.F., Smith W.D., Ratti Júnior J., Martins C.L., Amarante A.F. Vaccination of grazing calves with antigens from the intestinal membranes of Haemonchus contortus: effects against natural challenge with Haemonchus placeiand Haemonchus similis. Int. J. Parasitol. 2014, 44:687-702.
6. Bennett C.E., Threadgold L.T. Fasciola hepatica: development of tegument during migration in mouse. Exp. Parasitol. 1975, 38:38-55.
7. Bodian D.L., Davis S.J., Morgan B.P., Rushmere N.K. Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, CD59. J. Exp. Med. 1997, 185:507-516.
8. Boray J.C. Experimental fascioliasis in Australia. Adv. Parasitol. 1969, 7:95-210.
9. Boray J.C., Crowfoot P.D., Strong M.B., Allison J., Schellenbaum M., Von Orelli M., Sarasin R. Treatment of immature and mature Fasciola hepatica infections in sheep with triclabendazole. Vet. Record 1983, 113:315-317.
10. Boyce W.M., Courtney C.H., Loggins P.E. Resistance to experimental infection with Fasciola hepatica in exotic and domestic breeds of sheep. Int. J. Parasitol. 1987, 17:1233-1237.
11. Braschi S., Wilson R.A. Proteins exposed at the adult schistosome surface revealed by biotinylation. Mol. Cell Proteomics 2006, 5:347-356.
12. Braschi S., Curwen R.S., Ashton P.D., Verjovski-Almeida S., Wilson A. The tegument surface membranes of the human blood parasite Schistosoma mansoni: a proteomic analysis after differential extraction. Proteomics 2006, 6:1471-1482.
13. Brockwell Y.M., Elliott T.P., Anderson G.R., Stanton R., Spithill T.W., Sangster N.C. Confirmation of Fasciola hepatica resistant to triclabendazole in naturally infected Australian beef and dairy cattle. Int. J. Parasitol. Drugs Drug Res. 2014, 4:48-54.
14. Buffoni L., Zafra R., Pérez-Ecija A., Martínez-Moreno F.J., Martínez-Galisteo E., Moreno T., Pérez J., Martínez-Moreno A. Immune response of goats immunised with glutathione S-transferase and experimentally challenged with Fasciola hepatica. Parasitol. Int. 2010, 59:147-153.
15. Buffoni L., Martínez-Moreno F.J., Zafra R., Mendes R.E., Pérez-Écija A., Sekiya M., Mulcahy G., Pérez J., Martínez-Moreno A humoral immune response in goats immunised with cathepsin L1, peroxiredoxin and Sm14 antigen and experimentally challenged with Fasciola hepatica. Vet. Parasitol. 2012, 185:315-321.
16. Cai P., Bu L., Wang J., Wang Z., Zhong X., Wang H. Molecular characterization of Schistosoma japonicum tegument protein tetraspanin 2: sequence variation and possible implications for immune evasion. Biochem. Biophys. Res. Commun. 2008, 372:197-202.
17. Cardoso F.C., Pinho J.M.R., Azevedo V., Oliveira S.C. Identification of a new Schistosoma mansoni membrane-bound protein through bioinformatic analysis. Genet. Mol. Res. 2006, 5:609-618.
18. Cardoso F.C., Macedo G.C., Gava E., Kitten G.T., Vitor, Mati L., de Melo A.L., Caliari M.V., Almeida G.T., Venancio T.M., Verjovski-Almeida S., Oliveira S.C. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection. PLOS Negl. Trop. Dis. 2008, 2:e308.
19. Castro-Borges W., Dowle A., Curwen R., Thomas-Oates J., Wilson R.A. Mass spectrometric identification of exposed proteins on the surface of the schistosome tegument released by enzymatic shaving: a rational approach for selection of vaccine candidates. PLOS Negl. Trop. Dis. 2011, 5:e993.
20. Castro-Borges W., Simpson D.M., Dowle A., Curwen R.S., Thomas-Oates J., Beynon R.J., Wilson R.A. Abundance of tegument surface proteins in the human blood fluke Schistosoma mansoni determined by QconCAT proteomics. J. Proteomics 2011, 74:1519-1533.
21. Chauvin A., Bouvet G., Boulard C. Humoral and cellular immune responses to Fasciola hepatica experimental primary and secondary infection in sheep. Int. J. Parasitol. 1995, 25:1227-1241.
22. Corba J., Armour J., Roberts R.J., Urquhart G.M. Transfer of immunity to Fasciola hepatica infection by lymphoid cells. Res. Vet. Sci. 1971, 12:292-295.
23. Correa-Oliveira R., Pearce E.J., Oliveira G.C., Golgher D.B., Katz N., Bahia L.G., Carvalho O.S., Gazzinelli G., Sher A. The human immune response to defined immunogens of Schistosoma mansoni: elevated antibody levels to paramyosin in stool-negative individuals from two endemic areas in Brazil. Trans. R. Soc. Trop. Med. Hyg. 1989, 83:798-804.
24. Da'dara A.A., Skelly P.J., Wang M.M., Harn D.A. Immunization with plasmid DNA encoding the integral membrane protein, Sm23, elicits a protective immune response against schistosome infection in mice. Vaccine 2001, 20:359-369.
25. Da'dara A.A., Li Y.S., Xiong T., Zhou J., Williams G.M., McManus D.P., Feng Z., Yu X.L., Gray D.J., Harn D.A. DNA-based vaccines protect against zoonotic schistosomiasis in water buffalo. Vaccine 2008, 26:3617-3625.
26. Dalton J.P., Joyce P. Characterization of surface glycoproteins and proteins of different developmental stages of Fasciola hepatica by surface radiolabeling. J. Parasitol. 1987, 73:1281-1284.
27. Dalton J.P., McGonigle S., Rolph T.P., Andrews S.J. Induction of protective immunity in cattle against infection with Fasciola hepatica by vaccination with cathepsin L proteinases and with hemoglobin. Infect. Immun. 1996, 64:5066-5074.
28. Dalton J.P., Skelly P., Halton D.W. Role of the tegument and gut in nutrient uptake by parasitic platyhelminths. Can. J. Zool. 2004, 82:211-232.
29. Dalton J.P., Robinson M.W., Mulcahy G., O'Neill S.M., Donnelly S. Immunomodulatory molecules of Fasciola hepatica: candidates for both vaccine and immunotherapeutic development. Vet. Parasitol. 2013, 195:272-285.
30. Dargie J.D. The impact on production and mechanisms of pathogenesis of trematode infections in cattle and sheep. Int. J. Parasitol. 1987, 17:453-463.
31. Davies A., Simmons D.L., Hale G., Harrison R.A., Tighe H., Lachmann P.J., Waldmann H. CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J. Exp. Med. 1989, 170:637-654.
32. Davies C., Goose J. Killing of newly excysted juveniles of Fasciola hepatica in sensitized rats. Parasite Immunol. 1981, 3:81-96.
33. de Carvalho G.B.F., Pacífico L.G.G., Pimenta D.L.F., Siqueira L.M.V., Teixeira-Carvalho A., Coelho P.M.Z., Pinheiro C.D., Fujiwara R.T., Oliveira S.C., Fonseca C.T. Evaluation of the use of C-terminal part of the Schistosoma mansoni 200kDa tegumental protein in schistosomiasis diagnosis and vaccine formulation. Exp. Parasitol. 2014, 139:24-32.
34. De Bont J., Claerebout E., Riveau G., Schacht A.M., Smets K., Conder G., Brake D.A., Capron A., Vercruysse J. Failure of a recombinant Schistosoma bovis-derived glutathione S-transferase to protect cattle against experimental Fasciola hepatica infection. Vet. Parasitol. 2003, 113:135-144.
35. Dewilde S., Ioanitescu A.I., Kiger L., Gilany K., Marden M.C., Van Doorslaer S., Vercruysse J., Pesce A., Nardini M., Bolognesi M., Moens L. The hemoglobins of the trematodes Fasciola hepatica and Paramphistomum epiclitum: a molecular biological, physico-chemical, kinetic, and vaccination study. Protein Sci. 2008, 17:1653-1662.
36. Duffus W.P.H., Franks D. In vitro effect of immune serum and bovine granulocytes on juvenile Fasciola hepatica. Clin. Exp. Immunol. 1980, 41:430-440.
37. Durbin C.G. Longevity of the liver fluke, Fasciola sp, in sheep. Proc. Helminthol. Soc Washington 1952, 19:121.
38. El-Ahwany E., Rabia I., Nagy F., Zoheiry M., Diab T., Zada S. Protective role of purified cysteine proteinases against Fasciola gigantica infection in experimental animals. Korean J. Parasitol. 2012, 50:45-51.
39. Elliott T., Muller A., Brockwell Y., Murphy N., Grillo V., Toet H.M., Anderson G., Sangster N., Spithill T.W. Evidence for high genetic diversity of NAD1 and COX1 mitochondrial haplotypes among triclabendazole resistant and susceptible populations and field isolates of Fasciola hepatica (liver fluke) in Australia. Vet. Parasitol. 2014, 200:90-96.
40. Estuningsih E., Smooker P.M., Wiedosari E., Widjajanti S., Vaiano S., Partoutomo S., Spithill T.W. Evaluation of antigens of Fasciola gigantica as vaccines against tropical fasciolosis in cattle. Int. J. Parasitol. 1997, 27:1419-1428.
41. Estuningsih E., Spithill T., Raadsma H., Law R., Adiwinata G., Meeusen E., Piedrafita D. Development and application of a fecal antigen diagnostic sandwich ELISA for estimating prevalence of Fasciola gigantica in cattle in central Java, Indonesia. J. Parasitol. 2009, 95:450-455.
42. Fabiyi J.P. Production losses and control of helminths in ruminants of tropical regions. Int. J. Parasitol. 1987, 17:435-442.
43. Fairweather I. Triclabendazole: new skills to unravel an old(ish) enigma. J. Helminthol. 2005, 79:227-234.
44. Fairweather I. Reducing the future threat from (liver) fluke: realistic prospect or quixotic fantasy?. Vet. Parasitol. 2011, 180:133-143.
45. Farias L.P., Krautz-Peterson G., Tararam C.A., Araujo-Montoya B.O., Fraga T.R., Rofatto H.K., Silva-Jr F.P., Isaac L., Da'dara A.A., Wilson R.A., Shoemaker C.B., Leite L.C.C. On the three-finger protein domain fold and CD59-like proteins in Schistosoma mansoni. PLOS Negl. Trop. Dis. 2013, 7:e2482.
46. Flynn R.J., Irwin J.A., Olivier M., Sekiya M., Dalton J.P., Mulcahy G. Alternative activation of ruminant macrophages by Fasciola hepatica. Vet. Immunol. Immunopathol. 2007, 120:31-40.
47. Flynn R.J., Mulcahy G. The roles of IL-10 and TGF-beta in controlling IL-4 and IFN-gamma production during experimental Fasciola hepatica infection. Int. J. Parasitol. 2008, 38:1673-1680.
48. Flynn R.J., Mulcahy G., Elsheikha H.M. Coordinating innate and adaptive immunity in Fasciola hepatica infection: implications for control. Vet. Parasitol. 2010, 169:235-240.
49. Galat A., Gross G., Drevet P., Sato A., Mènez A. Conserved structural determinants in three-fingered protein domains. FEBS J. 2008, 275:3207-3225.
50. Gaudier J.F., Cabán-Hernández K., Osuna A., Espino A.M. Biochemical characterization and differential expression of a 16.5-kilodalton tegument-associated antigen from the liver fluke Fasciola hepatica. Clin. Vaccine Immunol. 2012, 19:325-333.
51. Gaze S., Driguez P., Pearson M.S., Mendes T., Doolan D.L., Trieu A., McManus D.P., Gobert G.N., Periago M.V., Oliveira R.C., Cardoso F.C., Oliveira G., Nakajima R., Jasinskas A., Hung C., Liang L., Pablo J., Bethony J.M., Felgner P.L., Loukas A. An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas. PLoS Pathog. 2014, 10:e1004033.
52. Geldhof P., De Maere V., Vercruysse J., Claerebout E. Recombinant expression systems: the obstacle to helminth vaccines?. Trends Parasitol. 2007, 23:527-532.
53. Gerke V., Moss S.E. Annexins: from structure to function. Physiol. Rev. 2002, 82:331-371.
54. Golden O., Flynn R.J., Read C., Sekiya M., Donnelly S.M., Stack C., Dalton J.P., Mulcahy G. Protection of cattle against a natural infection of Fasciola hepatica by vaccination with recombinant cathepsin L1 (rFhCL1). Vaccine 2010, 28:5551-5557.
55. Hacariz O., Sayers G., Mulcahy G. A preliminary study to understand the effect of Fasciola hepatica tegument on naive macrophages and humoral responses in an ovine model. Vet. Immunol. Immunopathol. 2011, 139:245-249.
56. Haçariz O., Sayers G., Baykal A.T. A proteomic approach to investigate the distribution and abundance of surface and internal Fasciola hepatica proteins during the chronic stage of natural liver fluke infection in cattle. J. Proteome Res. 2012, 11:3592-3604.
57. Haçariz O., Baykal A.T., Akgün M., Sagiroglu M.S., Sayers G.P. Generating a detailed protein profile of Fasciola hepatica during the chronic stage of infection in cattle. Proteomics 2014, 14:1519-1530.
58. Hanna R.E.B. Fasciola hepatica: an immunofluorescent study of antigenic changes in the tegument during development in the rat and the sheep. Exp. Parasitol. 1980, 50:155-170.
59. Hanna R.E.B. Fasciola hepatica: glycocalyx replacement in the juvenile as a possible mechanism for protection against host immunity. Exp. Parasitol. 1980, 50:103-114.
60. Haroun E.M., Hillyer G.V. Resistance to fascioliasis - a review. Vet. Parasitol. 1986, 20:63-93.
61. Hawkins C.D., Morris R.S. Depression of productivity in sheep infected with Fasciola hepatica. Vet. Parasitol. 1978, 4:341-351.
62. Hayes M.J., Moss S.E. Annexins and disease. Biochem. Biophys. Res. Commun. 2004, 322:1166-1170.
63. Hemler M.E. Tetraspanin functions and associated microdomains. Nat. Rev. Mol. Cell. Biol. 2005, 6:801-811.
64. Hewitson J.P., Grainger J.R., Maizels R.M. Helminth immunoregulation: the role of parasite secreted proteins in modulating host immunity. Mol. Biochem. Parasitol. 2009, 167:1-11.
65. Hillyer G.V., Haroun E.M., Hernandez A., De Galanes M.S. Acquired resistance to Fasciola hepatica in cattle using a purified adult worm antigen. Am. J. Trop. Med. Hyg. 1987, 37:363-369.
66. Hillyer G.V. Fasciola antigens as vaccines against fascioliasis and schistosomiasis. J. Helminthol. 2005, 79:241-247.
67. Hofmann A., Osman A., Leow C.Y., Driguez P., McManus D.P., Jones M.K. Parasite annexins-new molecules with potential for drug and vaccine development. Bioessays 2010, 32:967-976.
68. Hope-Cawdery M.J. Review of the economic importance of fascioliasis in sheep and cattle. Irish Vet. News Sept. 1984, 14-22.
69. Hope-Cawdery M.J., Crowe P.J., Strickland K.L., Conway A. Production levels of liver fluke Fasciola hepatica in cattle. I. The effects of infection on liveweight gain, feed intake and food conversion efficiency in beef cattle. Br. Vet. J. 1977, 133:145-159.
70. Hoyle D.V., Dalton J.P., Chase-Topping M., Taylor D.W. Pre-exposure of cattle to drug-abbreviated Fasciola hepatica infections: the effect upon subsequent challenge infection and the early immune response. Vet. Parasitol. 2003, 111:65-82.
71. Hughes D.L. Fasciola and fascioloides. Immune Responses in Parasitic Infections: Immunology, Immunopathology, and Immunoprophylaxis. vol. II: Trematodes and cestodes 1987, 91-114. CRC Press, Florida. E.J.L. Soulsby (Ed.).
72. Jayaraj R., Piedrafita D., Dynon K., Grams R., Spithill T.W., Smooker P.M. Vaccination against fasciolosis by a multivalent vaccine of stage-specific antigens. Vet. Parasitol. 2009, 160:230-236.
73. Jezek J., El Ridi R., Salah M., Wagih A., Aziz H.W., Tallima H., El Shafie M.H., Khalek T.A., Ammou F.F., Strongylis C., Moussis V., Tsikaris V. Fasciola gigantica cathepsin L proteinase-based synthetic peptide for immunodiagnosis and prevention of sheep fasciolosis. Biopolymers 2008, 90:349-357.
74. Kitadokoro K., Bordo D., Galli G., Petracca R., Falugi F., Abrignani S., Grandi G., Bolognesi M. CD81 extracellular domain 3D structure: insight into the tetraspanin superfamily structural motifs. EMBO J. 2001, 20:12-18.
75. Kumar N., Anju V., Gaurav N., Chandra D., Samanta S., Gupta S.C., Adeppa J., Raina O.K. Vaccination of buffaloes with Fasciola gigantica recombinant glutathione S-transferase and fatty acid binding protein. Parasitol. Res. 2012, 110:419-426.
76. Lammas D.A., Duffus W.P., Taylor D.W. Identification of surface proteins of juvenile stages of Fasciola hepatica. Res. Vet. Sci. 1985, 38:248-249.
77. Lanar D.E., Pearce E.J., James S.L., Sher A. Identification of paramyosin as schistosome antigen recognized by intradermally vaccinated mice. Science 1986, 234:593-596.
78. López-Abán J., Casanueva P., Nogal J., Arias M., Morrondo P., Diez-Baños P., Hillyer G.V., Martínez-Fernández A.R., Muro A. Progress in the development of Fasciola hepatica vaccine using recombinant fatty acid binding protein with the adjuvant adaptation system ADAD. Vet. Parasitol. 2007, 145:287-296.
79. López-Abán J., Nogal-Ruiz J.J., Vicente B., Morrondo P., Diez-Baños P., Hillyer G.V., Martínez-Fernández A.R., Feliciano A.S., Muro A. The addition of a new immunomodulator with the adjuvant adaptation ADAD system using fatty acid binding proteins increases the protection against Fasciola hepatica. Vet. Parasitol. 2008, 153:176-181.
80. Ludolf F., Patrocinio P.R., Correa-Oliveira R., Gazzinelli A., Falcone F.H., Teixeira-Ferreira A., Perales J., Oliveira G.C., Silva-Pereira R.A. Serological screening of the Schistosoma mansoni adult worm proteome. PLoS Negl. Trop. Dis. 2014, 8:e2745.
81. Maggioli G., Acosta D., Silveira F., Rossi S., Giacaman S., Basika T., Gayo V., Rosadilla D., Roche L., Tort J., Carmona C. The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep. Vaccine 2011, 29:9057-9063.
82. Malone J.B., Loyacano A., Armstrong D.A., Archibald L.F. Bovine fascioliasis: economic impact and control in Gulf Coast cattle based on seasonal transmission. Bovine Pract. 1982, 17:126-133.
83. Martínez-Fernández A.R., Nogal-Ruiz J.J., López-Abán J., Ramajo V., Oleaga A., Manga-González Y., Hillyer G.V., Muro A. Vaccination of mice and sheep with Fh12 FABP from Fasciola hepatica using the new adjuvant/immunomodulator system ADAD. Vet. Parasitol. 2004, 126:287-298.
84. Mas-Coma S., Bargues M.D., Valero M.A. Fascioliasis and other plant-borne trematode zoonoses. Int. J. Parasitol. 2005, 35:1255-1278.
85. McCausland I., Vandegraaff R., Nugent L. Fascioliasis in dairy cows on irrigated pasture. Aust. Vet. J. 1980, 56:324-326.
86. McManus D.P., Dalton J.P. Vaccines against the zoonotic trematodes Schistosoma japonicum, Fasciola hepatica and Fasciola gigantica. Parasitology 2006, 133(Suppl):S43-S61.
87. Mendes R.E., Zafra R., Pérez-Ecija R.A., Buffoni L., Martínez-Moreno A., Tendler M., Pérez J. Evaluation of local immune response to Fasciola hepatica experimental infection in the liver and hepatic lymph nodes of goats immunized with Sm14 vaccine antigen. Mem. Inst. Oswaldo Cruz. 2010, 105:698-705.
88. Mendes R.E., Pérez-Ecija R.A., Zafra R., Buffoni L., Martínez-Moreno A., Dalton J.P., Mulcahy G., Pérez J. Evaluation of hepatic changes and local and systemic immune responses in goats immunized with recombinant peroxiredoxin (Prx) and challenged with Fasciola hepatica. Vaccine 2010, 28:2832-2840.
89. Moreau, E., Chauvin, A., 2010. Immunity against helminths: interactions with the host and the intercurrent infections. J. Biomed. Biotechnol. 428593.
90. Morphew R.M., Hamilton C.M., Wright H.A., Dowling D.J., O'Neill S.M., Brophy P.M. Identification of the major proteins of an immune modulating fraction from adult Fasciola hepatica released by Nonidet P40. Vet. Parasitol. 2013, 191:379-385.
91. Morrison C.A., Colin T., Sexton J.L., Bowen F., Wicker J., Friedel T., Spithill T.W. Protection of cattle against Fasciola hepatica infection by vaccination with glutathione S-transferase. Vaccine 1996, 14:1603-1612.
92. Moss S.E., Morgan R.O. Annexins. Genome Biol. 2004, 5:219.
93. Mulcahy G., O'Connor F., McGonigle S., Dowd A., Clery D.G., Andrews S.J., Dalton J.P. Correlation of specific antibody titre and avidity with protection in cattle immunised against Fasciola hepatica. Vaccine 1998, 16:932-939.
94. Mulcahy G., O'Connor F., Clery D., Hogan S.F., Dowd A.J., Andrews S.J., Dalton J.P. Immune responses of cattle to experimental anti-Fasciola hepatica vaccines. Res. Vet. Sci. 1999, 67:27-33.
95. Mulvenna J., Moertel L., Jones M.K., Nawaratna S., Lovas E.M., Gobert G.N., Colgrave M., Jones A., Loukas A., McManus D.P. Exposed proteins of the Schistosoma japonicum tegument. Int. J. Parasitol. 2010, 40:543-554.
96. Mulvenna J., Sripa B., Brindley P.J., Gorman J., Jones M.K., Colgrave M.L., Jones A., Nawaratna S., Laha T., Suttiprapa S., Smout M.J., Loukas A. The secreted and surface proteomes of the adult stage of the carcinogenic human liver fluke Opisthorchis viverrini. Proteomics 2010, 10:1063-1078.
97. Nambi P.A., Yadav S.C., Raina O.K., Sriveny D., Saini M. Vaccination of buffaloes with Fasciola gigantica recombinant fatty acid binding protein. Parasitol. Res. 2005, 97:129-135.
98. Parizade M., Arnon R., Lachmann P.J., Fishelson Z. Functional and antigenic similarities between a 94-kD protein of Schistosoma mansoni (SCIP-1) and human CD59. J. Exp. Med. 1994, 179:1625-1636.
99. Paykari H., Dalimi A., Madani R. Immunization of sheep against Fasciola gigantica with glutathione S-transferase. Vet. Parasitol. 2002, 105:153-159.
100. Pearson M.S., Pickering D.A., McSorley H.J., Bethony J.M., Tribolet L., Dougall A.M., Hotez P.J., Loukas A. Enhanced protective efficacy of a chimeric form of the schistosomiasis vaccine antigen Sm-TSP-2. PLoS Neg. Trop. Dis. 2012, 6:e1564.
101. Pérez-Ecija R.A., Mendes R.E., Zafra R., Buffonni L., Martínez-Moreno A., Pérez J. Pathological and parasitological protection in goats immunised with recombinant cathepsin L1 and challenged with Fasciola hepatica. Vet. J. 2010, 185:351-353.
102. Piacenza L., Acosta D., Basmadjian I., Dalton J.P., Carmona C. Vaccination with cathepsin L proteinases and with leucine aminopeptidase induces high levels of protection against fascioliasis in sheep. Infect. Immun. 1999, 67:1954-1961.
103. Piedrafita D., Parsons J.C., Sandeman R.M., Wood P.R., Estuningsih S.E., Partoutomo S., Spithill T.W. Antibody-dependent cell-mediated cytotoxicity to newly excysted juvenile Fasciola hepatica in vitro is mediated by reactive nitrogen intermediates. Parasite Immunol. 2001, 23:473-482.
104. Piedrafita D., Raadsma H.W., Prowse R., Spithill T.W. Immunology of the host-parasite relationship in fasciolosis (Fasciola hepatica and Fasciola gigantica). Can. J. Zool. 2004, 82:233-250.
105. Piedrafita D., Estuningsih E., Pleasance J., Prowse R.K., Raadsma H.W., Meeusen E.N.T., Spithill T.W. Peritoneal lavage cells of Indonesian thin-tail sheep mediate antibody-dependent superoxide radical cytotoxicity in vitro against newly excysted juvenile Fasciola gigantica but not juvenile Fasciola hepatica. Infect. Immun. 2007, 75:1954-1963.
106. Piedrafita D., Spithill T.W., Smith R.E., Raadsma H.W. Improving animal and human health through understanding liver fluke immunology. Parasite Immunol. 2010, 32:572-581.
107. Piedrafita D.P., de Veer M.J., Sherrard J., Kraska T., Elhay M., Meeusen E.N. Field vaccination of sheep with a larval-specific antigen of the gastrointestinal nematode, Haemonchus contortus, confers significant protection against an experimental challenge infection. Vaccine 2012, 30:7199-7204.
108. Pinheiro C.S., Martins V.P., Assis N.R.G., Figueiredo B.C.P., Morais S.B., Azevedo V., Oliveira S.C. Computational vaccinology: an important strategy to discover new potential S. mansoni vaccine candidates. J. Biomed. Biotechnol. 2011, 2011:1-9.
109. Pinheiro C.S., Ribeiro A.P., Cardoso F.C., Martins V.P., Figueiredo B.C., Assis N.R., Morais S.B., Caliari M.V., Loukas A., Oliveira S.C. A multivalent chimeric vaccine composed of Schistosoma mansoni SmTSP-2 and Sm29 was able to induce protection against infection in mice. Parasite Immunol. 2014, 36:303-312.
110. Piratae S., Tesana S., Jones M.K., Brindley P.J., Loukas A., Lovas E., Eursitthichai V., Sripa B., Thanasuwan S., Laha T. Molecular characterization of a tetraspanin from the human liver fluke, Opisthorchis viverrini. PLoS Negl. Trop. Dis. 2012, 6:e1939.
111. Pleasance J., Raadsma H.W., Estuningsih S.E., Meeusen E., Piedrafita D. Innate and adaptive resistance of Indonesian Thin Tail sheep to liver fluke: a comparative analysis of Fasciola gigantica and F. hepatica infection. Vet. Parasitol. 2011, 178:264-272.
112. Pleasance J., Wiedosari E., Raadsma H.W., Meeusen E., Piedrafita D. Resistance to liver fluke infection in the natural host is correlated with a type-1 cytokine response. Parasite Immunol. 2011, 33:495-505.
113. Raadsma H.W., O'Meara T.J., Egerton J.R., Lehrbach P.R., Schwartzkoff C.L. Protective antibody titres and antigenic competition in multivalent Dichelobacter nodosus fimbrial vaccines using characterised rDNA antigens. Vet. Immunol. Immunopathol. 1994, 40:253-274.
114. Raina O.K., Nagar G., Varghese A., Prajitha G., Alex A., Maharana B.R., Joshi P. Lack of protective efficacy in buffaloes vaccinated with Fasciola gigantica leucine aminopeptidase and peroxiredoxin recombinant proteins. Acta Trop. 2011, 118:217-222.
115. Ramajo V., Oleaga A., Casanueva P., Hillyer G.V., Muro A. Vaccination of sheep against Fasciola hepatica with homologous fatty acid binding proteins. Vet. Parasitol. 2001, 97:35-46.
116. Reddington J.J., Leid R.W., Wescott R.B. A review of the antigens of Fasciola hepatica. Vet. Parasitol. 1984, 14:209-229.
117. Roberts J.A., Estuningsih E., Widjayanti S., Wiedosari E., Partoutomo S., Spithill T.W. Resistance of Indonesian thin tail sheep against Fasciola gigantica and F. hepatica. Vet. Parasitol. 1997, 68:69-78.
118. Roberts J.A., Widjajanti S., Estuningsih E., Hetzel D.J. Evidence for a major gene determining the resistance of Indonesian thin tail sheep against Fasciola gigantica. Vet. Parasitol. 1997, 68:309-314.
119. Roberts J.A., Estuningsih E., Wiedosari E., Spithill T.W. Acquisition of resistance against Fasciola gigantica by Indonesian thin tail sheep. Vet. Parasitol. 1997, 73:215-224.
120. Sacre S.M., Moss S.E. Intracellular localization of endothelial cell annexins is differentially regulated by oxidative stress. Exp. Cell Res. 2002, 274:254-263.
121. Schillhorn van Veen T.W. Fascioliasis (Fasciola gigantica) in West Africa: a review. Vet. Bull. 1980, 50:529-533.
122. Seigneuret M., Delaguillaumie A., Lagaudrière-Gesbert C., Conjeaud H. Structure of the Tetraspanin main extracellular domain. A partially conserved fold with a structurally variable domain insertion. J. Biol. Chem. 2001, 276:40055-40064.
123. Sexton J.L., Milner A.R., Panaccio M., Waddington J., Wijffels G.L., Chandler D., Thompson C., Wilson L., Spithill T.W., Mitchell G.F., Campbell N.J. Glutathione S-transferase. Novel vaccine against Fasciola hepatica infection in sheep. J. Immunol. 1990, 145:3905-3910.
124. Shi Y., Toet H., Rathinasamy V., Young N.D., Gasser R.B., Beddoe T., Huang W., Spithill T.W. First insight into CD59-like molecules of adult Fasciola hepatica. Exp. Parasitol. 2014, 144:57-64.
125. Smith R.E., Spithill T.W., Pike R.N., Meeusen E.N.T., Piedrafita D. Fasciola hepatica and Fasciola gigantica: cloning and characterisation of 70kDa heat-shock proteins reveals variation in HSP70 gene expression between parasite species recovered from sheep. Exp. Parasitol. 2008, 118:536-542.
126. Spithill T.W., Piedrafita D., Smooker P.M. Immunological approaches for the control of Fasciolosis. Int. J. Parasitol. 1997, 27:1221-1235.
127. Spithill T.W., Smooker P.M., Copeman D.B. Chapter 15. Fasciola gigantica: Epidemiology, control, immunology and molecular biology. Fasciolosis 1999, 465-525. CABI Publishing, Oxon. J.P. Dalton (Ed.).
128. Spithill T.W., Smooker P.M., Sexton J.L., Bozas E., Morrison C.A., Parsons J.C. Chapter 11. The development of vaccines against fasciolosis. Fasciolosis 1999, 377-410. CABI Publishing, Oxon. J.P. Dalton (Ed.).
129. Spithill T.W., Carmona C., Piedrafita D., Smooker P.M. Prospects for immunoprophylaxis against Fasciola hepatica (Liver Fluke). Parasitic Helminths: Targets, Screens, Drugs, and Vaccines 2012, 467-486. Wiley-VCH Verlag GmbH and Co., KGaA, Weinheim. First ed. C.R. Caffrey (Ed.).
130. Tran H.M., Pearson M.S., Bethony J.M., Smyth D.J., Jones M.K., Duke M., Don T.A., McManus D.P., Correa-Oliveira R., Loukas A. Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nat. Med. 2006, 12:835-840.
131. Trudgett A., McNair A.T., Hoey E.M., Keegan P.S., Dalton J.P., Rima B.K., Miller A., Ramasamy P. The major tegumental antigen of Fasciola hepatica contains repeated elements. Parasitology 2000, 121:185-191.
132. van Balkom B.W., van Gestel R.A., Brouwers J.F., Krijgsveld J., Tielens A.G., Heck A.J., van Hellemond J.J. Mass spectrometric analysis of the Schistosoma mansoni tegumental sub-proteome. J. Proteome Res. 2005, 4:958-966.
133. Vercruysse J., Claerebout E. Treatment vs non-treatment of helminth infections in cattle: defining the threshold. Vet. Parasitol. 2001, 98:195-214.
134. Villa-Mancera A., Quiroz-Romero H., Correa D., Ibarra F., Reyes-Pérez M., Reyes-Vivas H., López-Velázquez G., Gazarian K., Gazarian T., Alonso R.A. Induction of immunity in sheep to Fasciola hepatica with mimotopes of cathepsin L selected from a phage display library. Parasitology 2008, 135:1437-1445.
135. Villa-Mancera A., Méndez-Mendoza M. Protection and antibody isotype responses against Fasciola hepatica with specific antibody to pIII-displayed peptide mimotopes of cathepsin L1 in sheep. Vet. J. 2012, 194:108-112.
136. Villa-Mancera A., Reynoso-Palomar A., Utrera-Quintana F., Carreón-Luna L. Cathepsin L1 mimotopes with adjuvant Quil A induces a Th1/Th2 immune response and confers significant protection against Fasciola hepatica infection in goats. Parasitol. Res. 2014, 113:243-250.
137. Walker S.M., Prodöhl P.A., Hoey E.M., Fairweather I., Hanna R.E., Brennan G., Trudgett A. Substantial genetic divergence between morphologically indistinguishable populations of Fasciola suggests the possibility of cryptic speciation. Int. J. Parasitol. 2012, 42:1193-1199.
138. Wedrychowicz H., Kesik M., Kaliniak M., Kozak-Cieszczyk M., Jedlina-Panasiuk L., Jaros S., Plucienniczak A. Vaccine potential of inclusion bodies containing cysteine proteinase of Fasciola hepatica in calves and lambs experimentally challenged with metacercariae of the fluke. Vet. Parasitol. 2007, 147:77-88.
139. Wiedosari E., Copeman D.B. High resistance to experimental infection with Fasciola gigantica in Javanese thin-tailed sheep. Vet. Parasitol. 1990, 37:101-111.
140. Wijffels G.L., Salvatore L., Dosen M., Waddington J., Wilson L., Thompson C., Campbell N., Sexton J., Wicker J., Bowen F., Friedel T., Spithill T.W. Vaccination of sheep with purified cysteine proteases of Fasciola hepatica decreases worm fecundity. Exp. Parasitol. 1994, 78:132-148.
141. Wilson R.A., Smith G., Thomas M.R. Fascioliasis. The Population Dynamics of Infectious Diseases: Theory and Applications 1982, 262-319. Chapman and Hall, London. R.M. Anderson (Ed.).
142. Wilson R.A., Wright J.M., Castro-Borges W., Parker-Manuel S.J., Dowle A.A., Ashton P.D., Young N.D., Gasser R.B., Spithill T.W. Exploring the Fasciola hepatica tegument proteome. Int. J. Parasitol. 2011, 41:1347-1359.
143. Young N.D., Jex A.R., Cantacessi C., Hall R.S., Campbell B.E., Spithill T.W., Tangkawattana S., Tangkawattana P., Laha T., Gasser R.B. A portrait of the transcriptome of the neglected trematode, Fasciola gigantica - biological and biotechnological implications. PLoS Med. 2011, 5:e1004.
144. Yuan C., Fu Y., Li J., Yue Y., Cai L., Xiao W., Chen J., Yang L. Schistosoma japonicum: efficient and rapid purification of the tetraspanin extracellular loop 2, a potential protective antigen against schistosomiasis in mammalian. Exp. Parasitol. 2010, 126:456-461.
145. Zafra R., Buffoni L., Martínez-Moreno A., Pérez-Ecija A., Martinez-Moreno F.J., Pérez J.A. A study of the liver of goats immunized with a synthetic peptide of the Sm14 antigen and challenged with Fasciola hepatica. J. Comp. Pathol. 2008, 139:169-176.
146. Zafra R., Pérez-Écija R.A., Buffoni L., Moreno P., Bautista M.J., Martínez-Moreno A., Mulcahy G., Dalton J.P., Pérez J. Early and late peritoneal and hepatic changes in goats immunized with recombinant cathepsin L1 and infected with Fasciola hepatica. J. Comp. Pathol. 2013, 148:373-384.
147. Zhang W., Li J., Duke M., Jones M.K., Kuang L., Zhang J., Blair D., Li Y., McManus D.P. Inconsistent protective efficacy and marked polymorphism limits the value of Schistosoma japonicum tetraspanin-2 as a vaccine target. PLoS Negl. Trop. Dis. 2011, 5:e1166.
148. Zhang M., Hong Y., Han Y., Han H., Peng J., Qiu C., Yang J., Lu K., Fu Z., Lin J. Proteomic analysis of tegument-exposed proteins of female and male Schistosoma japonicum worms. J. Proteome Res. 2013, 12:5260-5270.